Stock Making Headlines: Facebook FB Stock is Great But Overvalued

Indigo analyst N. Landell-Mills is impressed with the latest results from Facebook Inc (NASDAQ FB) and Google Inc (NASDAQ GOOG), as each have managed to keep revenue growth high in competitive market segments, but that doesn’t mean he thinks that either company is an attractive investment. He expects the combination of slowing growth and the end of QE to cause double digit percentage point drops … Continue reading Stock Making Headlines: Facebook FB Stock is Great But Overvalued

AAPL NASDAQ AAPL Apple

Stock in Focus: A Look at Apple (NASDAQ AAPL) Stock before iPhone 6 Launch

Apple Inc (NASDAQ AAPL) is expected to unveil the much-anticipated iPhone 6 at an event on Sept. 9, and analysts have been expecting great things for the company’s stock. They say that this time, shares won’t fall after the announcement. Instead, many believe the exact opposite thing will happen. Analysts believe that with the iPhone 6 launch, Apple stock may not see the decline it … Continue reading Stock in Focus: A Look at Apple (NASDAQ AAPL) Stock before iPhone 6 Launch

Active Biotech Stocks: Kite Pharma Drug

Kite Pharma, Inc (KITE) announced the publication of positive results from an ongoing phase I-IIa study on KTE-C19 in patients suffering from aggressive non-Hodgkin’s lymphoma in the Aug 25, 2014 issue of the American Society of Clinical Oncology’s Journal of Clinical Oncology. In the phase I-II study, KTE-C19 achieved 92% overall objective response rate. According to Kite Pharma, out of 13 patients with advanced B-cell … Continue reading Active Biotech Stocks: Kite Pharma Drug

Biotech stock market news

Biotech Stocks: Amicus Therapeutics (FOLD) Soars High After Positive Results

Shares of Amicus Therapeutics (FOLD) soared 20.4% after the company announced positive data from its second phase III study (Study 012) on the oral small molecule chaperone migalastat HCl in Fabry patients with amenable mutations. The phase III study is evaluating the use of oral migalastat to standard-of-care enzyme replacement therapies (ERTs) − Sanofi’s (SNY) Fabrazyme and Shire’s (SHPG) Replagal − for Fabry disease. Eighteen-month … Continue reading Biotech Stocks: Amicus Therapeutics (FOLD) Soars High After Positive Results

Stock in Focus: Microsoft (NASDAQ MSFT) Offshore Cash

Microsoft Corp (NASDAQ MSFT) is currently sitting on almost $29.6 billion it would owe in US taxes if it repatriated the $92.9 billion of earnings it is keeping offshore, according to disclosures in the company’s most recent annual filings with the Securities and Exchange Commission. The amount of money that Microsoft is keeping offshore represents a significant spike from prior years, and the levies the … Continue reading Stock in Focus: Microsoft (NASDAQ MSFT) Offshore Cash

Stock in News: Google Buys Zync Reader

Google Inc (NASDAQ GOOG) announced that it has acquired special effects startup Zync Render, bringing the company that rendered the special effects for Looper, Star Trek Into Darkness and dozens of other feature films to its Cloud Platform and making its billing plan more flexible to avoid losing clients in the transition. Unlike previous cloud acquisitions, Google will require Zync clients to start using its … Continue reading Stock in News: Google Buys Zync Reader